223 related articles for article (PubMed ID: 31712410)
1. Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.
Zhang J; Sun W; Kong X; Zhang Y; Yang HJ; Ren C; Jiang Y; Chen M; Chen X
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24259-24267. PubMed ID: 31712410
[TBL] [Abstract][Full Text] [Related]
2. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
3. The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.
El Husseini N; Hales BF
Toxicol Sci; 2018 Apr; 162(2):439-449. PubMed ID: 29228353
[TBL] [Abstract][Full Text] [Related]
4. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
[TBL] [Abstract][Full Text] [Related]
5. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells.
Yugawa T; Narisawa-Saito M; Yoshimatsu Y; Haga K; Ohno S; Egawa N; Fujita M; Kiyono T
Cancer Res; 2010 May; 70(10):4034-44. PubMed ID: 20442293
[TBL] [Abstract][Full Text] [Related]
6. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
[TBL] [Abstract][Full Text] [Related]
7. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
8. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
9. NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner.
Cai BH; Bai ZY; Lien CF; Yu SJ; Lu RY; Wu MH; Wu WC; Chen CC; Hsu YC
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327630
[TBL] [Abstract][Full Text] [Related]
10. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
11. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
Venkatanarayan A; Raulji P; Norton W; Flores ER
Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells.
Cai BH; Wu PH; Chou CK; Huang HC; Chao CC; Chung HY; Lee HY; Chen JY; Kannagi R
Sci Rep; 2019 Jan; 9(1):950. PubMed ID: 30700826
[TBL] [Abstract][Full Text] [Related]
14. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915
[TBL] [Abstract][Full Text] [Related]
18. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li Y; Prives C
Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431
[TBL] [Abstract][Full Text] [Related]
19. p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1.
Laubach KN; Yan W; Kong X; Sun W; Chen M; Zhang J; Chen X
Proc Natl Acad Sci U S A; 2022 May; 119(22):e2123202119. PubMed ID: 35617425
[TBL] [Abstract][Full Text] [Related]
20.
Hof J; Kox C; Groeneveld-Krentz S; Bandapalli OR; Karawajew L; Schedel K; Kunz JB; Eckert C; Ludwig WD; Ratei R; Rhein P; Henze G; Muckenthaler MU; Kulozik AE; von Stackelberg A; Kirschner-Schwabe R
Haematologica; 2017 Jul; 102(7):e249-e252. PubMed ID: 28360149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
